| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 8,739,455 | $873,858,108.00 | 7.47% |
| U.S. Treasury 4.75% 2/15/2056 | Fixed Income | 323,254,600 | $314,011,523.00 | 2.69% |
| U.S. Treasury 5.00% 5/15/2046 | Fixed Income | 163,485,000 | $164,711,138.00 | 1.41% |
| U.S. Treasury 4.125% 6/30/2031 | Fixed Income | 138,608,500 | $138,126,614.00 | 1.18% |
| PacifiCorp 5.80% 4/15/2036 | Fixed Income | 88,696,000 | $91,074,117.00 | 0.78% |
| U.S. Treasury 4.375% 5/15/2036 | Fixed Income | 89,446,500 | $88,978,301.00 | 0.76% |
| RD Michigan Property Owner I, LLC 7.50% 3/30/2045 | Fixed Income | 86,111,000 | $85,873,678.00 | 0.73% |
| Abbott Laboratories 4.65% 3/15/2036 | Fixed Income | 84,796,000 | $82,369,478.00 | 0.7% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 77,669,000 | $77,924,686.00 | 0.67% |
| Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 76,118,000 | $77,649,190.00 | 0.66% |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) | Fixed Income | 72,235,000 | $70,170,090.00 | 0.6% |
| New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 | Fixed Income | 85,298,000 | $70,509,459.00 | 0.6% |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 69,251,000 | $69,125,240.00 | 0.59% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 66,997,000 | $67,740,600.00 | 0.58% |
| Bank of America Corp. 5.045% 2/6/2037 (USD-SOFR + 1.13% on 2/6/2036) | Fixed Income | 67,970,000 | $66,968,462.00 | 0.57% |